CANSINOBIO (06185): Zuo Min and Ji Xuefeng are elected as independent non-executive directors.
CanSino Biologics (06185) announced that Mr. Zuo Min and Ms. Ji Xuefeng were elected as independent non-executive directors of the third board of directors at the extraordinary general meeting.
CANSINOBIO (06185) announced that Mr. Zuo Min and Ms. Ji Xuefeng were elected as independent non-executive directors of the third board of directors at the extraordinary general meeting.
At the board meeting held immediately after the extraordinary general meeting, the board of directors decided to adjust the composition of the various committees under the board of directors, which will take effect from November 27, 2025 until the end of the third board of directors' term. The details of the adjusted committee composition are as follows:
Audit Committee: Mr. Zhang Yaoliang (Chairman), Ms. Ji Xuefeng, Mr. Li Zhicheng;
Remuneration and Assessment Committee: Mr. Zuo Min (Chairman), Mr. Zhang Yaoliang, Ms. Ji Xuefeng, Mr. Li Zhicheng, Dr. Xuefeng YU;
Nomination Committee: Ms. Ji Xuefeng (Chairman), Mr. Zuo Min, Dr. Xuefeng YU.
Related Articles

"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"

Guosen: RWA welcomes the era of strict supervision.

Wondershare Technology Group (300624.SZ) has upgraded its Wondershare Filmora desktop version: free video editing, better AI results!
"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"

Guosen: RWA welcomes the era of strict supervision.

Wondershare Technology Group (300624.SZ) has upgraded its Wondershare Filmora desktop version: free video editing, better AI results!

RECOMMEND

Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026

Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026

Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026


